Well Told Grants

Federal grant recipients / California

Federal grants to Virogenics, Inc.

San Diego, California · Small businesses · UEI UFJ8JM4CXU22

Virogenics, Inc. in San Diego, California received $10.9 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Aging Research, with $10.9 million. In fiscal 2025 it was awarded $1.6 million.

From USAspending.gov award records, updated October 31, 2026.

By year

Federal grants to Virogenics, Inc. by fiscal year
Fiscal yearAwardsAmount
FY 20211$2.5 million
FY 20221$2.8 million
FY 20230$0
FY 20242$4.0 million
FY 20251$1.6 million

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Virogenics, Inc.

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Aging Research 93.8663$10.9 million

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services3$10.9 million

Largest awards

The 3 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Phase 1 clinical trial of CMS121, a novel therapeutic candidate for alzheimer's disease - abstract this application requests supplemental funds for the funded grant, 1 R01 AG074447-01, which supports a first-in-human clinical trial of CMS121, a drug candidate for treatment of alzheimer's disease. Si
ASST_NON_R01AG074447_075 on USAspending
Aging ResearchSeptember 8, 2021$5.3 million
Long-term, non-clinical toxicology for advancing CMS121 to phase 2 trials for ad - abstract our goal is to advance CMS121 to a phase 2 clinical trial by conducting the long-term non-clinical toxicology studies needed to support a long-term course of daily administration to subjects with mild to mode
ASST_NON_U01AG084549_075 on USAspending
Aging ResearchSeptember 23, 2024$3.2 million
Paving the way to phase 2 trials of CMS121 for alzheimer's disease - nearly all of the many therapeutic drug candidates for the treatment of alzheimer's disease (AD) have failed in clinical trials. Although the two recently approved drugs for ad reduce aΒ plaque load, their long-term effects on the
ASST_NON_R44AG085775_075 on USAspending
Aging ResearchSeptember 26, 2024$2.4 million

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Virogenics, Inc. get?

$10.9 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Virogenics, Inc. the most?

The Department of Health and Human Services, with $10.9 million in 3 awards.

What is Virogenics, Inc.'s largest federal grant?

$5.3 million under Aging Research, with its first action in the period on September 8, 2021. That counts only the money obligated in fiscal 2021 to 2025.

Other grant recipients in San Diego

Largest federal grant recipients in California · Federal grants in California